Prevalence and predictors of non-alcoholic steatohepatitis in subjects with morbid obesity and with or without type 2 diabetes
Erminia Lembo(Università Cattolica del Sacro Cuore), Esmeralda Capristo(Università Cattolica del Sacro Cuore), Marco Raffaelli(Università Cattolica del Sacro Cuore), Luca Sessa(Saint Camillus International University of Health and Medical Sciences), Gianluigi Stefanizzi(Università Cattolica del Sacro Cuore), Danila Anello(Fondazione Santa Lucia), Laura Riccardi(Università Cattolica del Sacro Cuore), Maria Francesca Russo(Sapienza University of Rome), Amerigo Iaconelli(Università Cattolica del Sacro Cuore), Stefan R. Bornstein(King's College London), Ornella Verrastro(Agostino Gemelli University Polyclinic), Geltrude Mingrone(University of the Sacred Heart), Amalia Gastaldelli(National Research Council), Caterina Guidone(Agostino Gemelli University Polyclinic), Francesco Greco(Università Cattolica del Sacro Cuore), Maurizio Pompili, Luigi Ciccoritti(Agostino Gemelli University Polyclinic), Giulia Angelini(Università Cattolica del Sacro Cuore), Fabio Maria Vecchio(Agostino Gemelli University Polyclinic)
Cited by 22
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline
|The Journal of Clinical Endocrinology & Metabolism|2016|1.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.5k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k